Financials

  • Market Capitalization 8.49 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
10.76
Índice preço/fluxo de caixa
7.81

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
966
AXSM
Axsome Therapeutics, Inc. - Common Stock
169.03 USD+0.40%-4.67%-23.84%+29.82%8.85 B USD
970
CYTK
Cytokinetics, Incorporated - Common Stock
62.93 USD+0.03%-2.04%-14.39%+8.31%8.75 B USD
1043
SYRE
Spyre Therapeutics, Inc. - Common Stock
85.16 USD-0.62%-7.98%-6.00%+256.17%7.51 B USD
1044
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
44.89 USD-0.86%+4.23%-18.38%-37.76%7.46 B USD

Notícias